IMMUSE^™ News

The solution offers superior ease of formulation, potential application versatility, and more comprehensive immune support compared to probiotics and other immune health ingredients. Read More ›

Kirin Holdings Company, Limited (Kirin Holdings) announces that it will expand manufacturing equipment at the iMUSE Health Science Factory (located in Saitama Prefecture, just north of Tokyo) - a manufacturing center for lactic acid bacteria raw material - in order to meet the increasing demand for Kirin's proprietary Lactococcus lactis strain Plasma (L. lactis strain Plasma), the functional ingredient in the popular iMUSE brand of immune maintenance products. The new manufacturing equipment is scheduled to begin operating in 2023, and will double the annual production capacity of L. lactis strain Plasma to approximately 28 tons in 2023. Read More ›

PL-Immune™ features Setria® Glutathione and IMMUSE™, a new-to-market Lactococcus lactis strain Plasma (LC-Plasma), a unique paraprobiotic for more comprehensive immune support. Read More ›

Kyowa Hakko showcased the latest branded ingredient innovations including IMMUSE™ Lactococcus lactis strain Plasma and EYEMUSE™ Lacticaseibacillus paracasei KW3110. Read More ›

Kyowa Hakko Europe started sales promotion of Lactococcus lactis strain Plasma under the IMMUSE® brand in the European market on 20 April 2021. Lactococcus lactis strain Plasma is now available as an added-value health ingredient that can easily be added to foods, drinks or supplements made from European companies. Read More ›

Leading international health ingredient manufacturer Kyowa Hakko is excited to announce an interactive webinar will be held on Wednesday, October 7th at 2:00pm EDT with Natural Products Insider to discuss, and educate, on the newest approach that supports the immune system. Read More ›

International health ingredient manufacturer Kyowa Hakko Bio Co., Ltd. and parent company Kirin Holdings Co., Ltd. announce the launch of its novel dietary supplement ingredient IMMUSE™, delivering a new approach for broad range immune support. Read More ›